ERCC1 negative
|
HER2 Positive Breast Cancer
|
ERCC1 negative
|
HER2 Positive Breast Cancer
|
trastuzumab Resistant: C3 – Early Trials
|
trastuzumab Resistant: C3 – Early Trials
|
ERCC1 negative
|
Esophageal Adenocarcinoma
|
ERCC1 negative
|
Esophageal Adenocarcinoma
|
SOX Sensitive: C3 – Early Trials
|
SOX Sensitive: C3 – Early Trials
|